HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 202 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q3 2023. The put-call ratio across all filers is 0.36 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,669,903 | -63.9% | 81,474 | -61.2% | 0.29% | -63.0% |
| Q2 2023 | $7,389,900 | +33.0% | 210,000 | +23.5% | 0.78% | +27.7% |
| Q1 2023 | $5,555,600 | -58.0% | 170,000 | -29.2% | 0.61% | -55.8% |
| Q4 2022 | $13,224,000 | +7.3% | 240,000 | +1.3% | 1.38% | +7.0% |
| Q3 2022 | $12,324,000 | -2.8% | 237,000 | -8.8% | 1.29% | -10.5% |
| Q2 2022 | $12,680,000 | -2.8% | 260,000 | -3.1% | 1.44% | +11.9% |
| Q1 2022 | $13,050,000 | +37.0% | 268,244 | +21.9% | 1.29% | +103.2% |
| Q4 2021 | $9,528,000 | +21.3% | 220,000 | +7.4% | 0.63% | +15.1% |
| Q3 2021 | $7,853,000 | +178.2% | 204,876 | +104.9% | 0.55% | +187.0% |
| Q2 2021 | $2,823,000 | – | 100,000 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $367,614,941 | 98.94% |
| Nan Fung Group Holdings Ltd | 368,665 | $12,081,152 | 9.78% |
| venBio Partners LLC | 1,035,396 | $33,929,927 | 9.62% |
| Vivo Capital, LLC | 2,606,247 | $85,406,714 | 9.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 314,500 | $10,306,165 | 3.47% |
| AlphaCentric Advisors LLC | 122,000 | $3,997,940 | 2.27% |
| ASHFORD CAPITAL MANAGEMENT INC | 434,148 | $14,227,030 | 2.09% |
| Altium Capital Management LP | 117,000 | $3,834,090 | 2.00% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 595,490 | $19,514,207 | 1.90% |
| TANG CAPITAL MANAGEMENT LLC | 271,200 | $8,887,224 | 1.25% |